United States Federal Circuit

ResetAA Font size: Print

Regeneron Pharmaceuticals, Inc. v. Merus N.V., 16-1346

Affirming the district court's ruling that the plaintiff in a patent infringement suit's patent was unenforceable due to their inequitable conduct during prosecution of the patent, namely the withholding of four references specifically to deceive the Patent and Trademark Office.

Appellate Information

  • Argued
  • Submitted
  • Decided
  • Published 2017/07/27




  • United States Federal Circuit


FindLaw Career Center

    Select a Job Title

      Post a Job  |  View More Jobs

    View More